| Synonyms: | |
| Status: | Approved (2002) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N06AB10 |
| UNII: | 4O4S742ANY |
| InChI Key | WSEQXVZVJXJVFP-FQEVSTJZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H21FN2O |
| Molecular Weight | 324.4 |
| AlogP | 3.81 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 36.26 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
| Primary Target | |
|---|---|
| SERT |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
5100-5800 | 2-4600 | 3 | 1-7879 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Bipolar Disorder | 3 | D001714 | ClinicalTrials |
| Anxiety Disorders | 3 | D001008 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Obsessive-Compulsive Disorder | 3 | D009771 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Carcinoma | 3 | D002277 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
| Hypertension, Pulmonary | 3 | D006976 | ClinicalTrials |
| Bipolar Disorder | 3 | D001714 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Panic Disorder | 2 | D016584 | ClinicalTrials |
| Phobic Disorders | 2 | D010698 | ClinicalTrials |
| Phobia, Social | 2 | D000072861 | ClinicalTrials |
| Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
| Borderline Personality Disorder | 2 | D001883 | ClinicalTrials |
| Fibromyalgia | 2 | D005356 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Digestive System Diseases | 2 | D004066 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
| Aphasia | 2 | D001037 | ClinicalTrials |
| Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
| Alzheimer Disease | 1 | D000544 | ClinicalTrials |
| Hepatitis C | 1 | D006526 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 128196-01-0 |
| ChEBI | 36791 |
| ChEMBL | CHEMBL1508 |
| DrugBank | DB01175 |
| DrugCentral | 1053 |
| EPA CompTox | DTXSID8048440 |
| FDA SRS | 4O4S742ANY |
| Human Metabolome Database | HMDB0005028 |
| Guide to Pharmacology | 7177 |
| PDB | 68P |
| PharmGKB | PA10074 |
| PubChem | 146570 |
| SureChEMBL | SCHEMBL34948 |
| ZINC | ZINC000003800706 |